Liquid preparation and method for inhibiting degradation of penteic acid
By using a non-oxidizing gas to create a low-oxygen environment in the drug container, the problem of oxidative degradation of vitamin C or its salts when coexisting with pentiacin is solved, thereby improving the stability of the drug formulation and making it suitable for various liquid formulation systems.
Patent Information
- Application Number
- CN202610398864.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-27
- Publication Date
- 2026-05-26
AI Technical Summary
When vitamin C or its salts coexist with penteacin in a drug solution, the penteacin is easily degraded by oxidation, affecting the stability of the drug formulation. The degradation is exacerbated, especially under high temperature or radiation conditions.
By filling the drug container with a non-oxidizing gas, such as nitrogen, a low-oxygen environment is created, inhibiting the oxidative degradation of penteacin and maintaining the stability of the formulation.
It effectively inhibits the degradation of pentiacin, improves the physicochemical stability of drug formulations, and is suitable for various liquid formulation systems containing metal chelating agents and antioxidant excipients, especially for maintaining formulation quality under high temperature or radiation conditions.